Centric Health Corp. (TSE:CRX – Free Report) – Research analysts at Stifel Canada decreased their Q4 2024 earnings estimates for Centric Health in a research note issued on Tuesday, November 12th. Stifel Canada analyst J. Keywood now forecasts that the company will earn $0.02 per share for the quarter, down from their previous forecast of $0.03. Stifel Canada currently has a “Hold” rating on the stock. Stifel Canada also issued estimates for Centric Health’s FY2025 earnings at $0.10 EPS.
Separately, Ventum Cap Mkts raised Centric Health to a “strong-buy” rating in a report on Thursday, August 8th.
Centric Health Price Performance
Further Reading
- Five stocks we like better than Centric Health
- What is MarketRank™? How to Use it
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Top-Performing Non-Leveraged ETFs This Year
- How to invest in marijuana stocks in 7 steps
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
